The Difference Between Product Liability and Medical Malpractice in NEC Cases
The primary claims in NEC formula litigation are product liability claims against the formula manufacturers — Abbott and Mead Johnson — for manufacturing and selling a defective product without adequate warnings. These are distinct from medical malpractice claims, which involve the conduct of the hospital, NICU, neonatologists, or nurses who cared for the premature infant. A family may have both types of claims arising from the same NEC event. Product liability and medical malpractice claims are evaluated under different legal standards, involve different defendants and insurance carriers, and are often pursued separately or in different courts (federal MDL for manufacturer claims, state court for malpractice claims).
When Hospital Conduct May Give Rise to Malpractice Claims
Not every case of NICU formula feeding supports a medical malpractice claim — the standard for malpractice is deviation from the applicable standard of care, not simply that formula was administered. However, potential malpractice theories include: failure to offer or prioritize pasteurized donor breast milk when mother's own milk was unavailable or insufficient, in a NICU that had access to a donor milk program; failure to inform parents of the NEC risk associated with cow's milk formula so they could make an informed decision; delayed recognition and diagnosis of NEC when signs and symptoms were present; delayed escalation to surgical consultation or surgical intervention once NEC was confirmed; and failure to timely treat sepsis arising from NEC with appropriate antibiotics and hemodynamic support. An attorney experienced in both product liability and medical malpractice can evaluate whether the NICU's conduct fell below the standard of care in your case.
Practical Considerations for Hospital Claims
Medical malpractice claims involve additional procedural requirements in most states — including pre-suit expert affidavits, mandatory mediation, and caps on damages in some jurisdictions. The statute of limitations for malpractice claims may differ from the product liability SOL and is generally shorter for adult claimants, though minor tolling typically applies to protect the surviving infant's individual malpractice claim until age 18. Because malpractice claims require a deviation from the standard of care (not just a bad outcome), not every NEC case will support hospital liability. However, in NICUs that had access to donor breast milk programs and did not offer them, or where there was a clear delay in NEC diagnosis, the malpractice theory can be strong.
Frequently Asked Questions
Related Pages
NEC Disease Overview: Stages, Symptoms, and What Happens in the NICU
Necrotizing Enterocolitis is a staged disease. Early detection (Stage I) allows medical management; advanced NEC (Stage III) requires emergency bowel surgery with a mortality rate of 20-30%. Understanding the stages, warning signs, and typical NICU progression is essential for families trying to understand what happened to their baby and whether they have a legal claim.
NEC Evidence and Records: What to Gather and Why It Matters
Building a successful NEC formula case requires three categories of records: (1) NICU feeding logs documenting formula product and volume; (2) diagnostic records confirming the NEC diagnosis; and (3) long-term medical records documenting the lasting harm. You do not need these records before contacting an attorney — your attorney can obtain them for you — but understanding what is needed helps families gather and preserve evidence.
NEC Statute of Limitations: State-by-State Deadlines and Minor Tolling Rules
The statute of limitations for NEC formula cases is among the most nuanced in all of mass tort law. Most states toll the SOL for personal injury claims belonging to minor children until the child turns 18 — meaning surviving NEC children often have claims that will not expire for many years. Parents filing their own claims (wrongful death or loss of consortium) face shorter deadlines. Do not assume your claim is time-barred without consulting a NEC attorney.
NEC Formula Settlements and Verdicts: What Cases Have Resolved and For How Much
NEC formula cases have produced some of the most significant verdicts in the history of mass tort litigation, with individual jury awards ranging from $1.5 million to $495 million. MDL bellwether trials are actively shaping settlement values in 2025-2026. Understanding the landscape of resolved cases helps families calibrate the potential value of their own claims.
Similac NEC Lawsuit: Abbott Laboratories and Similac Special Care Formula
Abbott Laboratories manufactures Similac Special Care — the most widely used cow's milk-based premature infant formula in the United States. Abbott has faced thousands of NEC lawsuits across state and federal courts, with bellwether verdicts in MDL 3026 producing nine-figure jury awards. Families whose premature infants developed NEC after receiving Similac in the NICU may have viable product liability claims against Abbott.
Enfamil NEC Lawsuit: Mead Johnson/Reckitt and Enfamil Premature Formula
Mead Johnson Nutrition — now owned by the British consumer goods giant Reckitt — manufactures Enfamil Premature, a cow's milk-based premature infant formula widely used in NICUs. Mead Johnson has faced some of the largest NEC jury verdicts in history, including a $495 million verdict in Missouri and a $60 million verdict in Illinois. Families whose premature infants received Enfamil in the NICU should contact a NEC attorney immediately.
Why Premature Infants Are Uniquely Vulnerable to NEC
The extreme vulnerability of premature infants to NEC is not an unfortunate coincidence — it is a biological certainty rooted in the profound immaturity of the preterm gut. Understanding why preterm infants are uniquely at risk helps families understand both the medical reality of what happened to their baby and why the NEC risk associated with cow's milk formula should have been disclosed more clearly.
Breast Milk vs. Formula and NEC: AAP Guidelines and the Donor Milk Alternative
The American Academy of Pediatrics, the World Health Organization, and the Human Milk Banking Association of North America all recommend pasteurized donor breast milk — not cow's milk-based formula — as the preferred alternative when a mother's own milk is unavailable for premature infants. The failure of Abbott and Mead Johnson to acknowledge this guidance in their marketing to NICUs is central to the NEC litigation.
NEC MDL 3026 in the Northern District of Illinois: What Families Need to Know
MDL No. 3026 — In Re: Abbott Laboratories, et al., Preterm Infant Formula Products Liability Litigation — is pending before Chief Judge Rebecca R. Pallmeyer in the United States District Court for the Northern District of Illinois. Understanding how the MDL works, what the bellwether trial program has produced, and how your individual case fits into the larger litigation is essential for families considering filing a NEC formula claim.
NEC Wrongful Death Claims: When a Premature Baby Does Not Survive
Losing a premature baby to NEC is an unimaginable tragedy. Families who lost their infants after NEC developed following formula feeding in the NICU may have wrongful death claims against Abbott and Mead Johnson. These cases carry some of the highest verdicts in the NEC litigation — including nine-figure jury awards — because juries respond powerfully to the preventable death of a premature baby.
NEC Long-Term Disabilities: Short Bowel Syndrome, TPN, and Neurodevelopmental Harm
Surviving NEC is only the beginning of a long medical journey for many premature infants. Short Bowel Syndrome, TPN dependency, intestinal failure-associated liver disease, and neurodevelopmental disabilities including cerebral palsy and cognitive impairment are common long-term sequelae of NEC. These lifelong medical needs dramatically increase the damages available in surviving-infant NEC claims.
NEC Baby Formula (Similac/Enfamil) Lawsuit
Necrotizing Enterocolitis is one of the most catastrophic diseases affecting premature infants in the United States, striking approximately 12% of very-low-birthweight babies and carrying a mortality rate of 20-30%. Medical research spanning more than two decades has consistently linked cow's milk-based premature infant formula — particularly Similac Special Care (Abbott Laboratories) and Enfamil Premature (Mead Johnson/Reckitt) — to dramatically elevated NEC risk in preterm infants. Studies show that premature infants fed cow's milk-based formula are three to ten times more likely to develop NEC than those fed human breast milk or pasteurized donor breast milk. Despite this well-established scientific evidence and the recommendations of the American Academy of Pediatrics, Abbott and Mead Johnson continued to aggressively market their formula products to NICUs for use in the most vulnerable patient population in medicine. Thousands of families across the country have filed suit against these manufacturers, and the cases are now consolidated in Multi-District Litigation (MDL 3026) in the United States District Court for the Northern District of Illinois, before the Honorable Rebecca R. Pallmeyer. Families who lost a baby to NEC or whose infant survived with lasting harm deserve answers, accountability, and financial compensation for their loss.
View full case overview